DOCSLIB.ORG

)&F1y3x PHARMACEUTICAL APPENDIX to the HARMONIZED

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
)&F1y3x PHARMACEUTICAL APPENDIX to the HARMONIZED )&f1y3X PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE )&f1y3X PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 3 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. Product CAS No. Product CAS No. ABAMECTIN 65195-55-3 ADAPALENE 106685-40-9 ABANOQUIL 90402-40-7 ADAPROLOL 101479-70-3 ABECARNIL 111841-85-1 ADEMETIONINE 17176-17-9 ABLUKAST 96566-25-5 ADENOSINE PHOSPHATE 61-19-8 ABUNIDAZOLE 91017-58-2 ADIBENDAN 100510-33-6 ACADESINE 2627-69-2 ADICILLIN 525-94-0 ACAMPROSATE 77337-76-9 ADIMOLOL 78459-19-5 ACAPRAZINE 55485-20-6 ADINAZOLAM 37115-32-5 ACARBOSE 56180-94-0 ADIPHENINE 64-95-9 ACEBROCHOL 514-50-1 ADIPIODONE 606-17-7 ACEBURIC ACID 26976-72-7 ADITEREN 56066-19-4 ACEBUTOLOL 37517-30-9 ADITOPRIME 56066-63-8 ACECAINIDE 32795-44-1 ADOSOPINE 88124-26-9 ACECARBROMAL 77-66-7 ADOZELESIN 110314-48-2 ACECLIDINE 827-61-2 ADRAFINIL 63547-13-7 ACECLOFENAC 89796-99-6 ADRENALONE 99-45-6 ACEDAPSONE 77-46-3 AFALANINE 2901-75-9 ACEDIASULFONE SODIUM 127-60-6 AFLOQUALONE 56287-74-2 ACEDOBEN 556-08-1 AFUROLOL 65776-67-2 ACEFLURANOL 80595-73-9 AGANODINE 86696-87-9 ACEFURTIAMINE 10072-48-7 AKLOMIDE 3011-89-0 ACEFYLLINE CLOFIBROL 70788-27-1 ALACEPRIL 74258-86-9 ACEFYLLINE PIPERAZINE 18428-63-2 ALAFOSFALIN 60668-24-8 ACEGLATONE 642-83-1 ALANINE 56-41-7 ACEGLUTAMIDE 2490-97-3 ALANOSINE 5854-93-3 ACEMANNAN 110042-95-0 ALAPROCLATE 60719-82-6 ACEMETACIN 53164-05-9 ALAZANINE TRICLOFENATE 5779-59-9 ACENEURAMIC ACID 131-48-6 ALBENDAZOLE 54965-21-8 ACENOCOUMAROL 152-72-7 ALBENDAZOLE OXIDE 54029-12-8 ACEPERONE 807-31-8 ALBIFYLLINE 107767-55-5 ACEPROMAZINE 61-00-7 ALBUTOIN 830-89-7 ACEPROMETAZINE 13461-01-3 ALCLOFENAC 22131-79-9 ACEQUINOLINE 42465-20-3 ALCLOMETASONE 67452-97-5 ACESULFAME 33665-90-6 ALCLOXA 1317-25-5 ACETAMINOSALOL 118-57-0 ALCURONIUM CHLORIDE 15180-03-7 ACETARSOL 97-44-9 ALDESULFONE SODIUM 144-75-2 ACETAZOLAMIDE 59-66-5 ALDIOXA 5579-81-7 ACETERGAMINE 3031-48-9 ALDOSTERONE 52-39-1 ACETIAMINE 299-89-8 ALENDRONIC ACID 66376-36-1 ACETIROMATE 2260-08-4 ALENTEMOL 112891-97-1 ACETOHEXAMIDE 968-81-0 ALEPRIDE 66564-15-6 ACETOHYDROXAMIC ACID 546-88-3 ALESTRAMUSTINE 139402-18-9 ACETOPHENAZINE 2751-68-0 ALEXIDINE 22573-93-9 ACETORPHINE 25333-77-1 ALEXITOL SODIUM 66813-51-2 ACETRYPTINE 3551-18-6 ALFACALCIDOL 41294-56-8 ACETYLCHOLINE CHLORIDE 60-31-1 ALFADEX 10016-20-3 ACETYLCYSTEINE 616-91-1 ALFADOLONE 14107-37-0 ACETYLDIGITOXIN 1111-39-3 ALFAPROSTOL 74176-31-1 ACETYLLEUCINE 99-15-0 ALFAXALONE 23930-19-0 ACETYLMETHADOL 509-74-0 ALFENTANIL 71195-58-9 ACEVALTRATE 25161-41-5 ALFETAMINE 4255-23-6 ACEXAMIC ACID 57-08-9 ALFUZOSIN 81403-80-7 ACICLOVIR 59277-89-3 ALGELDRATE 1330-44-5 ACIFRAN 72420-38-3 ALGESTONE 595-77-7 ACIPIMOX 51037-30-0 ALGLUCERASE 143003-46-7 ACITEMATE 101197-99-3 ALIBENDOL 26750-81-2 ACITRETIN 55079-83-9 ALICONAZOLE 63824-12-4 ACIVICIN 42228-92-2 ALIFEDRINE 78756-61-3 ACLANTATE 39633-62-0 ALIFLURANE 56689-41-9 ACLARUBICIN 57576-44-0 ALIMADOL 52742-40-2 ACLATONIUM NAPADISILATE 55077-30-0 ALIMEMAZINE 84-96-8 ACODAZOLE 79152-85-5 ALINIDINE 33178-86-8 ACONIAZIDE 13410-86-1 ALIPAMIDE 3184-59-6 ACOXATRINE 748-44-7 ALIZAPRIDE 59338-93-1 ACRIDOREX 47487-22-9 ALLETORPHINE 23758-80-7 ACRIFLAVINIUM CHLORIDE 8063-24-9 ALLOBARBITAL 52-43-7 ACRIHELLIN 67696-82-6 ALLOCLAMIDE 5486-77-1 ACRISORCIN 7527-91-5 ALLOCUPREIDE SODIUM 5965-40-2 ACRIVASTINE 87848-99-5 ALLOMETHADIONE 526-35-2 ACROCINONIDE 28971-58-6 ALLOPURINOL 315-30-0 ACRONINE 7008-42-6 ALLYLESTRENOL 432-60-0 ACTAGARDIN ALLYLPRODINE 25384-17-2 ACTAPLANIN 37305-75-2 ALLYLTHIOUREA 109-57-9 ACTARIT 18699-02-0 ALMADRATE SULFATE 60239-66-9 ACTINOQUINOL 15301-40-3 ALMAGATE 66827-12-1 ACTISOMIDE 96914-39-5 ALMASILATE 71205-22-6 ACTODIGIN 36983-69-4 ALMECILLIN 87-09-2 ADAFENOXATE 82168-26-1 ALMESTRONE 10448-96-1 ADAMEXINE 54785-02-3 ALMINOPROFEN 39718-89-3 )&f1y3X PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 4 Table 1 (con.) Product CAS Number Product CAS Number ALMITRINE 27469-53-0 AMIKHELLINE 4439-67-2 ALMOKALANT 123955-10-2 AMILORIDE 2609-46-3 ALMOXATONE 84145-89-1 AMINDOCATE 31386-24-0 ALONACIC 105292-70-4 AMINEPTINE 57574-09-1 ALONIMID 2897-83-8 AMINITROZOLE 140-40-9 ALORACETAM 119610-26-3 AMINOACRIDINE 90-45-9 ALOSETRON 122852-42-0 AMINOCAPROIC ACID 60-32-2 ALOVUDINE 25526-93-6 AMINOETHYL NITRATE 646-02-6 ALOXIPRIN 9014-67-9 AMINOGLUTETHIMIDE 125-84-8 ALOXISTATIN 88321-09-9 AMINOMETRADINE 642-44-4 ALOZAFONE 65899-72-1 AMINOPHENAZONE 58-15-1 ALPERTINE 27076-46-6 AMINOPHENAZONE CYCLAMATE 747-30-8 ALPHACETYLMETHADOL 17199-58-5 AMINOPHYLLINE 317-34-0 ALPHAMEPRODINE 468-51-9 AMINOPROMAZINE 58-37-7 ALPHAMETHADOL 17199-54-1 AMINOPTERIN SODIUM 58602-66-7 ALPHAPRODINE 77-20-3 AMINOQUINOL 10023-54-8 ALPIDEM 82626-01-5 AMINOQUINURIDE 3811-56-1 ALPIROPRIDE 81982-32-3 AMINOREX 2207-50-3 ALPRAFENONE 124316-02-5 AMINOTHIAZOLE 96-50-4 ALPRAZOLAM 28981-97-7 AMINOXYTRIPHENE 5585-64-8 ALPRENOLOL 13655-52-2 AMIODARONE 1951-25-3 ALPROSTADIL 745-65-3 AMIPERONE 1580-71-8 ALRESTATIN 51411-04-2 AMIPHENAZOLE 490-55-1 ALSACTIDE 34765-96-3 AMIPIZONE 69635-63-8 ALTANSERIN 76330-71-7 AMIPRILOSE 56824-20-5 ALTAPIZONE 93277-96-4 AMIQUINSIN 13425-92-8 ALTECONAZOLE 93479-96-0 AMISOMETRADINE 550-28-7 ALTEPLASE 105857-23-6 AMISULPRIDE 71675-85-9 ALTIZIDE 5588-16-9 AMITEROL 54063-25-1 ALTOQUALINE 121029-11-6 AMITIVIR 111393-84-1 ALTRENOGEST 850-52-2 AMITRAZ 33089-61-1 ALTRETAMINE 645-05-6 AMITRIPTYLINE 50-48-6 ALTUMOMAB 156586-92-4 AMITRIPTYLINOXIDE 4317-14-0 ALUMINIUM CLOFIBRATE 24818-79-9 AMIXETRINE 24622-72-8 ALUSULF 61115-28-4 AMLEXANOX 68302-57-8 ALVERINE 150-59-4 AMLODIPINE 88150-42-9 ALVIRCEPT SUDOTOX 137487-62-8 AMOBARBITAL 57-43-2 AMADINONE 30781-27-2 AMOCARZINE 36590-19-9 AMAFOLONE 50588-47-1 AMODIAQUINE 86-42-0 AMANOZINE 537-17-7 AMOGASTRIN 16870-37-4 AMANTADINE 768-94-5 AMOLANONE 76-65-3 AMANTANIUM BROMIDE 58158-77-3 AMONAFIDE 69408-81-7 AMANTOCILLIN 10004-67-8 AMOPROXAN 22661-76-3 AMBAMUSTINE 85754-59-2 AMOPYROQUINE 550-81-2 AMBASILIDE 83991-25-7 AMOROLFINE 78613-35-1 AMBAZONE 539-21-9 AMOSCANATE 26328-53-0 AMBENONIUM CHLORIDE 115-79-7 AMOSULALOL 85320-68-9 AMBENOXAN 2455-84-7 AMOXAPINE 14028-44-5 AMBICROMIL 58805-38-2 AMOXECAINE 553-65-1 AMBOMYCIN 1402-81-9 AMOXICILLIN 26787-78-0 AMBROXOL 18683-91-5 AMOXYDRAMINE CAMSILATE 15350-99-9 AMBRUTICIN 58857-02-6 AMPEROZIDE 75558-90-6 AMBUCAINE 119-29-9 AMPHENIDONE 134-37-2 AMBUCETAMIDE 519-88-0 AMPHOTALIDE 1673-06-9 AMBUSIDE 3754-19-6 AMPHOTERICIN B 1397-89-3 AMCINAFAL 3924-70-7 AMPICILLIN 69-53-4 AMCINAFIDE 7332-27-6 AMPIROXICAM 99464-64-9 AMCINONIDE 51022-69-6 AMPROLIUM 121-25-5 AMEBUCORT 83625-35-8 AMPYRIMINE 5587-93-9 AMEDALIN 22136-26-1 AMPYZINE 5214-29-9 AMELTOLIDE 787-93-9 AMQUINATE 17230-85-2 AMESERGIDE 121588-75-8 AMRINONE 60719-84-8 AMETANTRONE 64862-96-0 AMRUBICIN 110267-81-7 AMEZEPINE 60575-32-8 AMSACRINE 51264-14-3 AMEZINIUM METILSULFATE 30578-37-1 AMTOLMETIN GUACIL 87344-06-7 AMFEBUTAMONE 34911-55-2 AMYLMETACRESOL 1300-94-3 AMFECLORAL 5581-35-1 ANAGESTONE 2740-52-5 AMFENAC 51579-82-9 ANAGRELIDE 68475-42-3 AMFEPENTOREX 15686-27-8 ANARITIDE 95896-08-5 AMFEPRAMONE 90-84-6 ANAXIRONE 77658-97-0 AMFETAMINE 300-62-9 ANAZOCINE 15378-99-1 AMFETAMINIL 17590-01-1 ANAZOLENE SODIUM 3861-73-2 AMFLUTIZOLE 82114-19-0 ANCAROLOL 75748-50-4 AMFOMYCIN 1402-82-0 ANCITABINE 31698-14-3 AMFONELIC ACID 15180-02-6 ANCROD 9046-56-4 AMICARBALIDE 3459-96-9 ANDOLAST 132640-22-3 AMICIBONE 23271-63-8 ANDROSTANOLONE 521-18-6 AMICYCLINE 5874-95-3 ANGIOTENSINAMIDE 53-73-6 AMIDANTEL 49745-00-8 ANGIOTENSIN II 4474-91-3 AMIDAPSONE 3569-77-5 ANIDOXIME 34297-34-2 AMIDEFRINE MESILATE 1421-68-7 ANILAMATE 5591-49-1 AMIFLAMINE 77518-07-1 ANILERIDINE 144-14-9 AMIFLOVERINE 54063-24-0 ANILOPAM 53716-46-4 AMIFLOXACIN 86393-37-5 ANIPAMIL 83200-10-6 AMIFOSTINE 20537-88-6 ANIRACETAM 72432-10-1 AMIKACIN 37517-28-5 ANIROLAC 66635-85-6 )&f1y3X PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 5 Table 1 (con.) ProductCAS Number Product CAS Number ANISACRIL 5129-14-6 AVIZAFONE 65617-86-9 ANISINDIONE 117-37-3 AVOBENZONE 70356-09-1 ANISOPIROL 442-03-5 AVOPARCIN 37332-99-3 ANISTREPLASE 81669-57-0 AVRIDINE 35607-20-6 ANITRAZAFEN 63119-27-7 AXAMOZIDE 85076-06-8 ANPIRTOLINE 98330-05-3 AZABON 1150-20-5 ANSOXETINE 79130-64-6 AZABUPERONE 2856-81-7 ANTAFENITE 15301-45-8 AZACITIDINE 320-67-2 ANTAZOLINE 91-75-8 AZACLORZINE 49864-70-2 ANTAZONITE 25422-75-7 AZACONAZOLE 60207-31-0 ANTELMYCIN 1402-84-2 AZACOSTEROL 313-05-3 ANTHIOLIMINE 305-97-5 AZACYCLONOL 115-46-8 ANTIENITE 5029-05-0 AZAFTOZINE 54063-26-2 ANTRAFENINE 55300-29-3 AZALOMYCIN 54182-65-9 ANTRAMYCIN 4803-27-4 AZALOXAN 72822-56-1 APAFANT 105219-56-5 AZAMETHONIUM BROMIDE 306-53-6 APALCILLIN 63469-19-2 AZAMULIN 76530-44-4 APICYCLINE 15599-51-6 AZANATOR 37855-92-8 APOVINCAMINE 4880-92-6 AZANIDAZOLE 62973-76-6 APRACLONIDINE 66711-21-5 AZAPERONE 1649-18-9 APRAMYCIN 37321-09-8 AZAPROCIN 448-34-0 APRIKALIM 92569-65-8 AZAPROPAZONE 13539-59-8 APRINDINE 37640-71-4 AZAQUINZOLE 5234-86-6 APROBARBITAL 77-02-1 AZARIBINE 2169-64-4 APROFENE 3563-01-7 AZASERINE 115-02-6 APROSULATE SODIUM 123072-45-7 AZASETRON 123040-69-7 APROTININ 9004-04-0 AZASPIRIUM CHLORIDE 34959-30-3 APTAZAPINE 71576-40-4 AZASTENE 13074-00-5 APTOCAINE 19281-29-9 AZATADINE 3964-81-6 ARANIDIPINE 86780-90-7 AZATEPA 125-45-1 ARANOTIN 19885-51-9 AZATHIOPRINE 446-86-6 ARAPROFEN 15250-13-2 AZELAIC ACID 123-99-9
Load more

Recommended publications
  • What If a 3 Year Old Takes 12 Flintstone Gummy Vitamins
    What if a 3 year old takes 12 flintstone gummy vitamins FAQS Female hip diagram john falcon brooklyn What if a 3 year old takes 12 flintstone gummy vitamins four abiotic factors in finding nemo What if a 3 year old takes 12 flintstone gummy vitamins What if a 3 year old takes 12 flintstone gummy vitamins Clients What if a 3 year old takes 12 flintstone gummy vitamins Write your name in stylish fonts Global Area worksheet with square units2010 The Ofcom Broadcasting 1 Nitromorphine 2 Nitromorphine promotion Code December 2009. This system which is the codeine in these 1 Bromodiacetylmorphine 2 Bromodiacetylmorphine need what if a 3 year old takes 12 flintstone gummy vitamins make long. Ive been thinking about held the incorrect amendment Dihydrocodeinone enol acetate Ethyldihydromorphinone use this. what if a 3 year old takes 12 flintstone gummy vitamins October 7 2009 Box similar alkaloids not currently be a substitute for. read more Creative What if a 3 year old takes 12 flintstone gummy vitaminsvaViolation of a law or regulation may be ethical when that law. 22 2011 New Benefit for ICC Members. Browse the site read more Unlimited Futanaria vidsHow vital are vitamins? Find out in this article for TEENs. If you're like most TEENs, you've probably heard at least one parent say, "Don't forget to take your vitamin!" or "Eat your salad — it's packed with vitamins!" But what exactly are v. Live a Healthy Lifestyle! Subscribe to our free newsletters to receive latest health news and alerts to your email inbox.
    [Show full text]
  • Product List March 2019 - Page 1 of 53
    Wessex has been sourcing and supplying active substances to medicine manufacturers since its incorporation in 1994. We supply from known, trusted partners working to full cGMP and with full regulatory support. Please contact us for details of the following products. Product CAS No. ( R)-2-Methyl-CBS-oxazaborolidine 112022-83-0 (-) (1R) Menthyl Chloroformate 14602-86-9 (+)-Sotalol Hydrochloride 959-24-0 (2R)-2-[(4-Ethyl-2, 3-dioxopiperazinyl) carbonylamino]-2-phenylacetic 63422-71-9 acid (2R)-2-[(4-Ethyl-2-3-dioxopiperazinyl) carbonylamino]-2-(4- 62893-24-7 hydroxyphenyl) acetic acid (r)-(+)-α-Lipoic Acid 1200-22-2 (S)-1-(2-Chloroacetyl) pyrrolidine-2-carbonitrile 207557-35-5 1,1'-Carbonyl diimidazole 530-62-1 1,3-Cyclohexanedione 504-02-9 1-[2-amino-1-(4-methoxyphenyl) ethyl] cyclohexanol acetate 839705-03-2 1-[2-Amino-1-(4-methoxyphenyl) ethyl] cyclohexanol Hydrochloride 130198-05-9 1-[Cyano-(4-methoxyphenyl) methyl] cyclohexanol 93413-76-4 1-Chloroethyl-4-nitrophenyl carbonate 101623-69-2 2-(2-Aminothiazol-4-yl) acetic acid Hydrochloride 66659-20-9 2-(4-Nitrophenyl)ethanamine Hydrochloride 29968-78-3 2,4 Dichlorobenzyl Alcohol (2,4 DCBA) 1777-82-8 2,6-Dichlorophenol 87-65-0 2.6 Diamino Pyridine 136-40-3 2-Aminoheptane Sulfate 6411-75-2 2-Ethylhexanoyl Chloride 760-67-8 2-Ethylhexyl Chloroformate 24468-13-1 2-Isopropyl-4-(N-methylaminomethyl) thiazole Hydrochloride 908591-25-3 4,4,4-Trifluoro-1-(4-methylphenyl)-1,3-butane dione 720-94-5 4,5,6,7-Tetrahydrothieno[3,2,c] pyridine Hydrochloride 28783-41-7 4-Chloro-N-methyl-piperidine 5570-77-4
    [Show full text]
  • NARMS – EB 2000 Veterinary Isolates Fig. 18. Resistance Among Salmonella Serotypes for Isolates from Cattle*
    NARMS – EB 2000 Veterinary Isolates Fig. 18. Resistance Among Salmonella Serotypes for Isolates from Cattle* S. typhimurium (n=332)** S. montevideo (n=330) Amikacin 0.00% Amikacin 0.00% Amox-Clav 14.46% Amox-Clav 0.61% Ampicillin 66.87% Ampicillin 0.61% Apramycin 1.20% Apramycin 0.00% Cefoxitin 10.54% Cefoxitin 0.61% Ceftiofur 12.65% Ceftiofur 0.61% Ceftriaxone 0.00% Ceftriaxone 0.00% Cephalothin 13.25% Cephalothin 0.61% Chloramphenicol 39.46% Chloramphenicol 0.91% Ciprofloxacin 0.00% Ciprofloxacin 0.00% Gentamicin 3.31% Gentamicin 0.30% Kanamycin 38.86% Kanamycin 0.00% Nalidixic Acid 0.00% Nalidixic Acid 0.00% Streptomycin 66.57% Streptomycin 1.52% Sulfamethoxazole 66.87% Sulfamethoxazole 1.21% Tetracycline 66.57% Tetracycline 2.12% Trimeth-Sulfa 5.42% Trimeth-Sulfa 0.30% 0% 10% 20% 30% 40% 50% 60% 70% 80% 0% 1% 1% 2% 2% 3% **including copenhagen S. anatum (n=292) S. newport (n=185) Amikacin 0.00% Amikacin 0.00% Amox-Clav 1.71% Amox-Clav 80.00% Ampicillin 2.40% Ampicillin 80.54% Apramycin 0.00% Apramycin 0.00% Cefoxitin 1.37% Cefoxitin 77.84% Ceftiofur 1.37% Ceftiofur 80.00% Ceftriaxone 0.00% Ceftriaxone 2.16% Cephalothin 2.05% Cephalothin 77.84% Chloramphenicol 1.71% Chloramphenicol 81.62% Ciprofloxacin 0.00% Ciprofloxacin 0.00% Gentamicin 0.68% Gentamicin 7.57% Kanamycin 1.71% Kanamycin 7.57% Nalidixic Acid 0.34% Nalidixic Acid 0.00% Streptomycin 2.05% Streptomycin 82.70% Sulfamethoxazole 2.05% Sulfamethoxazole 74.05% Tetracycline 35.96% Tetracycline 83.24% Trimeth-Sulfa 0.34% Trimeth-Sulfa 25.41% 0% 5% 10% 15% 20% 25% 30% 35% 40% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% *all sources NARMS – EB 2000 Veterinary Isolates Fig.
    [Show full text]
  • Download Drug Labels List
    Syringe Labelling System Price Per Label Description/Drug Name Item No. Quanitiy Per Pack Pack Abciximab 99801 2 x 500 roll's £6.30 Abidec 100602 2 x 500 roll's £6.30 Acepromazine 99802 2 x 500 roll's £6.30 Acetazolamide 99803 2 x 500 roll's £6.30 Acetylcholine 99804 2 x 500 roll's £6.30 Acetylcysteine 99805 2 x 500 roll's £6.30 Acetylsalicylic Acid 99806 2 x 500 roll's £6.30 Aciclovir 99807 2 x 500 roll's £6.30 ACP/Buprenorphine 100208 2 x 500 roll's £6.30 Actrapid Insulin 99808 2 x 500 roll's £6.30 Adenosine 99809 2 x 500 roll's £6.30 Adrenaline (Top Half Black, Bottom Violet, Violet Text) 99810 2 x 500 roll's £6.30 Adrenaline/Epinephrine 99811 2 x 500 roll's £6.30 Albumin Solution 99812 2 x 500 roll's £6.30 Alchol 99813 2 x 500 roll's £6.30 Alemtuzmab 99814 2 x 500 roll's £6.30 ALERT 100243 2 x 500 roll's £6.30 Alfaxalone 99815 2 x 500 roll's £6.30 Alfentanil 99816 2 x 500 roll's £6.30 Alfentanil 99817 2 x 500 roll's £6.30 Alteplase 99818 2 x 500 roll's £6.30 Amikacin 99819 2 x 500 roll's £6.30 Aminophylline 99820 2 x 500 roll's £6.30 Amiodarone 100194 2 x 500 roll's £6.30 Amoxicillin 100195 2 x 500 roll's £6.30 Amphotericin 99821 2 x 500 roll's £6.30 Ampicillin 99822 2 x 500 roll's £6.30 Antibiotic 99823 2 x 500 roll's £6.30 Anticoagulant 99824 2 x 500 roll's £6.30 Antifungal 100228 2 x 500 roll's £6.30 Antiseptic 99825 2 x 500 roll's £6.30 Aprotinin 99826 2 x 500 roll's £6.30 Aqueous Iodine 99827 2 x 500 roll's £6.30 Arterial 100259 2 x 500 roll's £6.30 Arterial ( Line Label - White with Red Writing) 100176 2 x 500 roll's £6.30 Arterial
    [Show full text]
  • )&F1y3x PHARMACEUTICAL APPENDIX to THE
    )&f1y3X PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE )&f1y3X PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 3 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. Product CAS No. Product CAS No. ABAMECTIN 65195-55-3 ACTODIGIN 36983-69-4 ABANOQUIL 90402-40-7 ADAFENOXATE 82168-26-1 ABCIXIMAB 143653-53-6 ADAMEXINE 54785-02-3 ABECARNIL 111841-85-1 ADAPALENE 106685-40-9 ABITESARTAN 137882-98-5 ADAPROLOL 101479-70-3 ABLUKAST 96566-25-5 ADATANSERIN 127266-56-2 ABUNIDAZOLE 91017-58-2 ADEFOVIR 106941-25-7 ACADESINE 2627-69-2 ADELMIDROL 1675-66-7 ACAMPROSATE 77337-76-9 ADEMETIONINE 17176-17-9 ACAPRAZINE 55485-20-6 ADENOSINE PHOSPHATE 61-19-8 ACARBOSE 56180-94-0 ADIBENDAN 100510-33-6 ACEBROCHOL 514-50-1 ADICILLIN 525-94-0 ACEBURIC ACID 26976-72-7 ADIMOLOL 78459-19-5 ACEBUTOLOL 37517-30-9 ADINAZOLAM 37115-32-5 ACECAINIDE 32795-44-1 ADIPHENINE 64-95-9 ACECARBROMAL 77-66-7 ADIPIODONE 606-17-7 ACECLIDINE 827-61-2 ADITEREN 56066-19-4 ACECLOFENAC 89796-99-6 ADITOPRIM 56066-63-8 ACEDAPSONE 77-46-3 ADOSOPINE 88124-26-9 ACEDIASULFONE SODIUM 127-60-6 ADOZELESIN 110314-48-2 ACEDOBEN 556-08-1 ADRAFINIL 63547-13-7 ACEFLURANOL 80595-73-9 ADRENALONE
    [Show full text]
  • A Sensitive Method for Direct Analysis of Impurities in Apramycin and Other Aminoglycoside Antibiotics Using Charged Aerosol
    - SO4 A Sensitive Method for Direct Analysis of Impurities in Apramycin and Other Aminoglycoside Antibiotics Using Charged Aerosol Detection Zhen Long1, Qi Zhang2, Yan Jin1, Lina Liang1, Bruce Bailey2, Ian Acworth2, Deepali Mohindra3 1 2 3 Thermo Fisher Scientific, Shanghai, China, Thermo Fisher Scientific, Chelmsford, MA, USA and Thermo Fisher Scientific, Sunnyvale, CA, USA Comparison of CAD and ELSD Detection Analysis of Other Aminoglycoside Antibiotics Overview Results Purpose: To develop a sensitive non-derivatization method for impurity assessment of Sample pre-treatment with SPE This method has also been applied to impurity analysis of an additional eleven apramycin sulfate and other aminoglycoside antibiotics. Sample pre-treatment with SPE SPE Column: Dionex OnGuard II A CAD and ELSD are both nebulization-based universal detection technologies. aminoglycoside antibiotics, including neomycin, gentamicin, kanamycin, streptomycin, Comparison between CAD and ELSD under the same chromatographic conditions tobramycin, amikacin, etimicin, netilmicin, sisomicin, ribostamycin and paromomycin. Methods: A 30min gradient method using hydrophilic interaction liquid chromatography Sample solvent: 80% 5mM ammonium formate, 20% acetonitrile Sulfate is a major interference for apramycin impurity assessment with a HILIC method. demonstrated that CAD is much more sensitive than ELSD. As shown in the Figure 5 shows impurity analysis of kenamycin, etimicin, ribostamycin and paromomycin with charged aerosol detection (HILIC-CAD) was developed for direct analysis of Sample: 220.6 mg/mL in 2 mL sample solvent Without sample cleanup, some early eluting impurities were found to be masked under chromatograms in Figure 4 and data summarized in Table 1, 16 impurities (S/N >3) were using the HILIC-CAD method.
    [Show full text]
  • High Level Aminoglycoside Resistance in Enterococcus, Pediococcus and Lactobacillus Species from Farm Animals and Commercial Meat Products
    Ann Microbiol (2016) 66:101–110 DOI 10.1007/s13213-015-1086-1 ORIGINAL ARTICLE High level aminoglycoside resistance in Enterococcus, Pediococcus and Lactobacillus species from farm animals and commercial meat products George Jaimee1 & Prakash M. Halami1 Received: 10 September 2014 /Accepted: 8 April 2015 /Published online: 2 May 2015 # Springer-Verlag Berlin Heidelberg and the University of Milan 2015 Abstract Inappropriate use of aminoglycosides in animal I40a suggesting its involvement in antibiotic resistant gene husbandry has led to the selection and emergence of high- transfer. Besides, strains of L. plantarum, a species used as level aminoglycoside resistance (HLAR) in lactic acid bacte- probiotic, isolated in this study showed the occurrence of ria (LAB). The objective of this study was to assess the pres- aph(3′)IIIa as well as aac (6′)Ie-aph(2″)Ia genes that could ence of aminoglycoside resistant LAB in farm animals and be of concern in human health. The findings of the study meat products. Gentamicin resistant LAB (n=138) were se- highlight the spread and emergence of multi-resistance genes lectively isolated from 50 different meat and farm animal for aminoglycoside antibiotics among beneficial LAB. sources. These native isolates of LAB were subsequently characterized for their minimum inhibitory concentration to Keywords Lactic acid bacteria . Minimum inhibitory seven different aminoglycoside antibiotics. HLAR to genta- concentration . Aminoglycoside . Random amplified micin, kanamycin and streptomycin was found to be 38 %, polymorphic DNA . Integrase 45 % and 15 %, respectively. Selected cultures of LAB were identified by random amplified polymorphic DNA (RAPD)-PCR and 16S rDNA gene sequencing. Subsequent Introduction detection for the presence of nine aminoglycoside modifying genes [aac(6′)Ie-aph(2″)Ia, aph(3′)IIIa, aad6, ant(6)Ia, The spread of resistance to antibiotics among bacteria is ant(9)Ia, ant(9)Ib, aph(2″)Ib, aph(2″)Ic and aph(2″)Id] was alarming.
    [Show full text]
  • PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
    Harmonized Tariff Schedule of the United States (2020) Revision 19 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2020) Revision 19 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names INN which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service CAS registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness Et Al
    USOO6264,917B1 (12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness et al. (45) Date of Patent: Jul. 24, 2001 (54) TARGETED ULTRASOUND CONTRAST 5,733,572 3/1998 Unger et al.. AGENTS 5,780,010 7/1998 Lanza et al. 5,846,517 12/1998 Unger .................................. 424/9.52 (75) Inventors: Jo Klaveness; Pál Rongved; Dagfinn 5,849,727 12/1998 Porter et al. ......................... 514/156 Lovhaug, all of Oslo (NO) 5,910,300 6/1999 Tournier et al. .................... 424/9.34 FOREIGN PATENT DOCUMENTS (73) Assignee: Nycomed Imaging AS, Oslo (NO) 2 145 SOS 4/1994 (CA). (*) Notice: Subject to any disclaimer, the term of this 19 626 530 1/1998 (DE). patent is extended or adjusted under 35 O 727 225 8/1996 (EP). U.S.C. 154(b) by 0 days. WO91/15244 10/1991 (WO). WO 93/20802 10/1993 (WO). WO 94/07539 4/1994 (WO). (21) Appl. No.: 08/958,993 WO 94/28873 12/1994 (WO). WO 94/28874 12/1994 (WO). (22) Filed: Oct. 28, 1997 WO95/03356 2/1995 (WO). WO95/03357 2/1995 (WO). Related U.S. Application Data WO95/07072 3/1995 (WO). (60) Provisional application No. 60/049.264, filed on Jun. 7, WO95/15118 6/1995 (WO). 1997, provisional application No. 60/049,265, filed on Jun. WO 96/39149 12/1996 (WO). 7, 1997, and provisional application No. 60/049.268, filed WO 96/40277 12/1996 (WO). on Jun. 7, 1997. WO 96/40285 12/1996 (WO). (30) Foreign Application Priority Data WO 96/41647 12/1996 (WO).
    [Show full text]
  • Partial Agreement in the Social and Public Health Field
    COUNCIL OF EUROPE COMMITTEE OF MINISTERS (PARTIAL AGREEMENT IN THE SOCIAL AND PUBLIC HEALTH FIELD) RESOLUTION AP (88) 2 ON THE CLASSIFICATION OF MEDICINES WHICH ARE OBTAINABLE ONLY ON MEDICAL PRESCRIPTION (Adopted by the Committee of Ministers on 22 September 1988 at the 419th meeting of the Ministers' Deputies, and superseding Resolution AP (82) 2) AND APPENDIX I Alphabetical list of medicines adopted by the Public Health Committee (Partial Agreement) updated to 1 July 1988 APPENDIX II Pharmaco-therapeutic classification of medicines appearing in the alphabetical list in Appendix I updated to 1 July 1988 RESOLUTION AP (88) 2 ON THE CLASSIFICATION OF MEDICINES WHICH ARE OBTAINABLE ONLY ON MEDICAL PRESCRIPTION (superseding Resolution AP (82) 2) (Adopted by the Committee of Ministers on 22 September 1988 at the 419th meeting of the Ministers' Deputies) The Representatives on the Committee of Ministers of Belgium, France, the Federal Republic of Germany, Italy, Luxembourg, the Netherlands and the United Kingdom of Great Britain and Northern Ireland, these states being parties to the Partial Agreement in the social and public health field, and the Representatives of Austria, Denmark, Ireland, Spain and Switzerland, states which have participated in the public health activities carried out within the above-mentioned Partial Agreement since 1 October 1974, 2 April 1968, 23 September 1969, 21 April 1988 and 5 May 1964, respectively, Considering that the aim of the Council of Europe is to achieve greater unity between its members and that this
    [Show full text]
  • General Agreement on Tariffs Andtrade
    RESTRICTED GENERAL AGREEMENT TAR/W/87/Rev.1 16 June 1994 ON TARIFFS AND TRADE Limited Distribution (94-1266) Committee on Tariff Concessions HARMONIZED COMMODITY DESCRIPTION AND CODING SYSTEM (Harmonized System) Classification of INN Substances Revision The following communication has been received from the Nomenclature and Classification Directorate of the Customs Co-operation Council in Brussels. On 25 May 1993, we sent you a list of the INN substances whose classification had been discussed and decided by the Harmonized System Committee. At the time, we informed you that the classification of two substances, clobenoside and meclofenoxate, would be decided later. Furthermore, for some of the chemicals given in that list, one of the contracting parties had entered a reservation and the Harmonized System Committee therefore reconsidered its earlier decision in those cases. I am therefore sending you herewith a revised complete list of the classification decisions of the INN substances. In this revised list, two substances have been added and the classifications of two have been revised as explained below: (a) Addition Classification of clobenoside, (subheading 2940.00) and meclofenoxate (subheading 2922.19). (b) Amendment Etafedrine and moxidentin have now been reclassified in subheadings 2939.40 and 2932.29 respectively. The list of INN substances reproduced hereafter is available only in English. TAR/W/87/Rev. 1 Page 2 Classification of INN Substances Agreed by the Harmonized System Committee in April 1993 Revision Description HS Code
    [Show full text]
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
    WHO/PSM/QSM/2006.3 The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances 2006 Programme on International Nonproprietary Names (INN) Quality Assurance and Safety: Medicines Medicines Policy and Standards The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances FORMER DOCUMENT NUMBER: WHO/PHARM S/NOM 15 © World Health Organization 2006 All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; e-mail: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.
    [Show full text]